A Little Rock, Ark., federal jury found Wyeth Pharmaceuticals and Upjohn (a Pfizer unit) liable for $27 million in punitive damages to Donna Scroggin, who sued the drug manufacturers in 2004 after developing breast cancer after taking hormone-replacement therapy. The award includes $19.3 million from Wyeth and $7.7 from Upjohn.

Wyeth manufactures Premarin, an estrogen replacement, and Prempro, which is a combination of estrogen and progestin. These, along with Upjohn’s Provera, which contains progestin, are commonly prescribed to treat the unpleasant effects of menopause.

Sales of Wyeth’s hormone-replacement drugs topped $2 billion before a 2002 study linked the medicines to a higher risk of breast cancer, according to a report published on Bloomberg.com. The article states that the Women’s Health Initiative study, which was sponsored by the U.S. National Institutes of Health, concluded that women who took a combination of estrogen and progestin, as found in Prempro, increased their risk of getting invasive breast cancer by 24 percent.

 

 



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Highly recommended

I would highly recommend this law firm to handle any of your legal needs.

—Sandy